Primary information |
---|
sequence ID | Seq_4942 |
Peptide sequence | LMIDQNTKSPLFMGKVVNPTQK |
CancerPDF_ID | CancerPDF_ID63, CancerPDF_ID8598, |
PMID | 16896061,23667664 |
Protein Name | Alpha-1-antitrypsin precursor,Alpha-1 antitrypsin |
UniprotKB Entry Name | A1AT_HUMAN,A1AT_HUMAN |
Fluid | Serum,Serum |
M/Z | 830.51,2488.32 |
Charge | 1,1 |
Mass (in Da) | 2489.3,2491 |
fdr | NA,NA |
Profiling Technique | MALDI-TOF,MALDI-TOF |
Peptide Identification technique | Q/TOF MS/MS,FT-ICR MS/MS + nano-HPLC |
Quantification Technique | NA,NA |
Labelled/Label Free | Label Free,Label Free |
FDR | NA,NA |
CancerPDF_ID | CancerPDF_ID63, CancerPDF_ID8598, |
p-Value | 1.00E-05,NA |
Software | MASCOT,MASCOT |
Length | 22,22 |
Cancer Type | Metastatic thyroid carcinomas,"Breast cancer, Lung cancer, Rectal cancer" |
Database | NCBI refseq Protein Database,NA |
Modification | NA,NA |
Number of Patients | 40 metastatic thyroid carcinoma patients and 40 normal for training phase and 10 metastatic thyroid carcinoma and 10 normal individuals for independent validation,"Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy" |
Regulation | NA,NA |
Validation | Independent validation,NA |
Sensitivity | 95% on independent dataset,NA |
Specificity | 95% on independent dataset,NA |
Accuracy | NA,NA |
Peptide Atlas | NA |
IEDB | |